Presentation Information
[S13-2]Usefulness of therapeutic drug monitoring of lenvatinib on clinical efficacy and adverse events in patients with hepatocellular carcinoma
○Kimitaka Suetsugu1, Kojiro Hata1, Takeshi Hirota1, Nobuaki Egashira1, Ichiro Ieiri1 (1. Dept. of Pharmacy, Kyushu Univ. Hosp.)
Password required to view
A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.